Sumitomo Dainippon Patents – Insights & Stats (Updated 2023)

Sumitomo Dainippon has a total of 103 patents globally, out of which 27 have been granted. Of these 103 patents, more than 68% patents are active. United States of America is where Sumitomo Dainippon has filed the maximum number of patents, followed by Canada and Mexico. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Sumitomo Dainippon.

Sumitomo Dainippon was founded in the year 2020. The Company manufactures, develops and sells pharmaceutical, food ingredients, food additives, veterinary medicines, and diagnostics products.

Do read about some of the most popular patents of Sumitomo Dainippon which have been covered by us in this article and also you can find Sumitomo Dainippon patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sumitomo Dainippon patent portfolio.

How many patents does Sumitomo Dainippon have?

Sumitomo Dainippon has a total of 103 patents globally. These patents belong to 44 unique patent families. Out of 103 patents, 71 patents are active.

How Many Patents did Sumitomo Dainippon File Every Year?

Sumitomo Dainippon Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSumitomo Dainippon Applications FiledSumitomo Dainippon Patents Granted
202254
2021104
2020176
2019101
2018121
201786
201613
201541
201451
20131
20122

Explore the top-performing drugs that dominate the Pharmaceutical Industry

Patent NumberCompanyProductBrandRevenuePatent Expiry Date
US9174975Sumitomo PharmaLurasidone HydrochlorideLatuda$1.75BJun-26
US7612199AlfasigmaRifaximinXifaxan$1.64BNov-24
US7902206AlfasigmaRifaximinXifaxan$1.64BNov-24
US8158644AlfasigmaRifaximinXifaxan$1.64BNov-24
US7371727Ironwood PharmaLinaclotideLinzess$1.00BMar-25

How many Sumitomo Dainippon patents are Alive/Dead?

Sumitomo Dainippon Patent Portfolio

 How Many Patents did Sumitomo Dainippon File in Different Countries?

Sumitomo Dainippon Worldwide Patent Filing

Countries in which Sumitomo Dainippon Filed Patents

CountryPatents
United States Of America23
Canada22
Mexico13
Hong Kong (S.A.R.)13
Israel5
Europe4
Singapore3
New Zealand2
Austria2
Philippines1
Indonesia1
Spain1
Malaysia1
Italy1

Where are Research Centres of Sumitomo Dainippon Patents Located?

R&D Centers of Sumitomo Dainippon

 10 Best Sumitomo Dainippon Patents

US20120058997A1 is the most popular patent in the Sumitomo Dainippon portfolio. It has received 30 citations so far from companies like Supergen, Tolero Pharmaceuticals and Califia Bio.

Below is the list of 10 most cited patents of Sumitomo Dainippon:

Publication NumberCitation Count
US20120058997A130
US8877803B227
US7998966B227
US20110269772A119
US20080214558A111
US9732055B27
US9745278B26
US9834532B24
US9730909B24
CA2959951A14

What are Sumitomo Dainippon key innovation segments?

What Technologies are Covered by Sumitomo Dainippon?

The chart below distributes patents filed by Sumitomo Dainippon in different countries on the basis of the technology protected in patents. It also represents the markets where Sumitomo Dainippon thinks it’s important to protect particular technology inventions.

R&D Focus: How has Sumitomo Dainippon search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Sumitomo Dainippon?

Related Articles

Orthotreat Patents – Insights & Stats (Updated 2024)

Orthotreat has a total of 5 patents globally, out of which no patents have been granted. Of these 5 patents, more than 80% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Orthotreat. Orthotreat was

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.